Table 5.

Viability of flies expressing one or two doses ofewgHS  transgenes

GenotypeanbViabilityc
Females
ewgl1/+; +/+; +/Tb 2040.84
 ewgl1/+; EWGHS7/+; +/Tb 1790.74
 ewgl1/+; +/+; EWGHS1/+d 2421.00
 ewgl1/+; EWGHS7/+; ewgHS1/+ 25 0.10
 +/+; +/+; +/Tb 2100.87
 +/+; EWGHS7/+; +/Tb 1720.71
 +/+; +/+; EWGHS1/+ 2380.98
 +/+; EWGHS7/+; EWGHS1/+ 28 0.12
Males
 ewgl1/Y; +/+; +/Tb 00
 ewgl1/Y; EWGHS7/+; +/Tb 1020.49
 ewgl1/Y; +/+; EWGHS1/+ 1700.82
 ewgl1/Y; EWGHS7/+; EWGHS1/+ 1 0.005
 +/Y; +/+; +/Tb 1710.83
 +/Y; EWGHS7/+; +/Tb 1580.76
 +/Y; +/+; EWGHS1/+d 2071.00
 +/Y; EWGHS7/+; EWGHS1/+ 1 0.005
  • a Females of the genotypeewgl1y w sn/w; +/+; EWGHS1/TM6,Tbwere crossed to yw/Y; +/+; EWGHS7 /+ males.

  • b n, number of flies.

  • c Viability of F1 genotypes;n/n of the most viable genotype of the same sex.

  • d Most viable genotype used as control to calculate viability.